Abstract:Abstract One of the invariant features of human cancer is unlimited proliferation, a hallmark conferred by telomerase in 90% tumors. Somatic mutations in the telomerase reverse transcriptase (TERT) gene promoter are highly recurrent in human cancers. Telomerase is also critically important in human stem cells, as evidenced by mutations in telomerase, which contribute to degenerative diseases. Despite the importance of telomerase in tissue maintenance, the identity of telomerase-positive cells has remained elusive, owing to low levels of the core telomerase components. The ability to isolate TERT-positive cells in vivo would significantly advance our understanding of telomerase regulation, tissue function and carcinogenesis. To address these issues, we created knock-in transcriptional reporters of TERT expression by replacing the TERT open reading frame with the red fluorescent protein, TdTomato. Among mouse tissues, telomerase activity is most strongly expressed in testis, a tissue in which resident stem cells fuel the continuous generation of male gametes. In human sperm, telomere lengths are preserved with age, although how this is achieved, in contrast to the age-dependent telomere shortening seen in somatic tissues, remains unresolved. Using TERTTdTomato/+ knock-in reporter mice, we found that only a rare subset of cells in mouse testis expresses high levels of TERT. By double immunostaining, these TERTHigh cells were synonymous with undifferentiated spermatogonia, the primitive cell population in which male germline stem cells reside. By FACS of the germ cells in testis, TERTHigh cells and TERTLow cells represent discrete populations that were further studied using additional markers. The undifferentiated spermatogonia in the TERTHigh population were further fractionated into GFRalpha+ and GFRalpha- populations. Cells in the TERTLow population were nearly all cKit+, consistent with their identification as differentiated spermatogonia. We characterized these populations in molecular and functional terms. Using RNAseq, we established a hierarchy among these populations according to which the TERTHigh GFRalpha1+ cells give rise to TERTHigh GFRalpha1- cells, which in turn yield TERTLow cKit+ cells. Surprisingly, in transplantation studies, TERTHigh GFRalpha1+ cells and TERTHigh GFRalpha1- cells possess comparable stem cell activity. These data suggest the existence of stem cell plasticity according to which cells in either primitive population retain stem cell potential. In contrast, TERTLow cKit+ cells fail to reconstitute spermatogenesis in transplantation experiments and therefore lack stem cell activity. These studies reveal marked transcriptional regulation of telomerase in vivo and show a strong concordance between stemness and telomerase levels in rare subsets of tissue stem cells in vivo. These findings indicate the existence of innate signaling pathways controlling TERT expression over a surprising dynamic range. Citation Format: Matthew Pech, Alina Garbuzov, Meena Sukhwani, Berenice Benayoun, Shengda Lin, Anne Brunet, Kyle Orwig, Steven E. Artandi. Encoding immortality: Transcriptional control of telomerase in stem cells in vivo. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 980. doi:10.1158/1538-7445.AM2015-980

Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation

Structural Basis for Reactivating the Mutant TERT Promoter by Cooperative Binding of P52 and ETS1.

Abstract 980: Encoding Immortality: Transcriptional Control of Telomerase in Stem Cells in Vivo

Argininosuccinate Lyase Drives Activation of Mutant TERT Promoter in Glioblastomas

Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players

Synergistic Activation of Mutant TERT Promoter by Sp1 and GABPA in BRAFV600E-driven Human Cancers

P-150 * RECURRENT TELOMERASE REVERSE TRANSCRIPTASE PROMOTER MUTATIONS IN NON-SMALL-CELL LUNG CANCERS

Discriminating Association of a Common Telomerase Reverse Transcriptase Promoter Polymorphism with Telomere Parameters in Non-Small Cell Lung Cancer with or Without Epidermal Growth Factor Receptor Mutation.

TERC Promotes Non-Small Cell Lung Cancer Progression by Facilitating the Nuclear Localization of TERT

Recurrent TERT Promoter Mutations in Non-Small Cell Lung Cancers.

An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase

Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications

Abstract 913: Tert Mutant Promoter Mouse Model Induces Cancer Progression in BrafV600E-driven Thyroid Tumors: A Novel Tool to Understand the Biology of Telomerase-Reactivated Cancers

Telomerase directly regulates NF-κB-dependent transcription

Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism

Promoter mutation-independent TERT expression is related to immune-enriched milieu in papillary thyroid cancer

TERT Accelerates BRAF Mutant-Induced Thyroid Cancer Dedifferentiation and Progression by Regulating Ribosome Biogenesis

Thyroid carcinoma-featured telomerase activation and telomere maintenance: Biology and translational/clinical significance

Biom-71. Expanding The Spectrum Oftert Promoter Non-Canonical Sequence Variants In Cns Tumors: A Case Series

BRAF-induced EHF expression affects TERT in aggressive papillary thyroid cancer

TERT activates endogenous retroviruses to promote an immunosuppressive tumour microenvironment